DRUG USE EVALUATION OF DIABETES MELLITUS IN NON-HOSPITALIZED PATIENTS
Keywords:
Diabetes Mellitus, Drug Use Evaluation, Anti Diabetic DrugsAbstract
Objective: As irrational drug administration in these patients can increase the overall burden of Diabetes Mellitus (DM) on the health system in different societies, we decided to investigate the patterns of antidiabetic drug administration and the way these patients are monitored in our community.
Methods: This is a prospective cross-sectional study performed in the city of Zabol in a 9 mo period. Diabetic patients, who referred to local pharmacies, were interviewed and data about their demographic characteristics, current and previous anti diabetic regimen, adverse drug reactions co morbidities as well as diabetes symptoms on diagnoses and its complications were collected.
Results: Our study showed that metformin was the most frequent used oral hypoglycemic agents (OHA) (66.4 %) followed by sulfonylurea, and the most prevalent combination therapy was metformin/glibenclamide regimen (28.5%). The majority of patients treated with metformin at the time when they were diagnosed with diabetes (45.3 %). In terms of co-existing disease and target organ damages, hypertension and visual impairment ranked first in our study population. Hypoglycemic episodes were most commonly reported adverse events with insulin and gastric upset with OHAs. 60.3% of our patients didn't follow regular blood glucose checkup.
Conclusion: It is concluded that the prescribing pattern in DM is moving from monotherapy with either insulin or sulfonylureas towards combination therapies. This study strongly highlights the need for patient education and comprehensive counseling about the importance of strict commitment to antidiabetic regimen, lifestyle modification, monitoring blood glucose as well as its related complications regularly, for successful management of diabetes.Â
Downloads
References
Khalam A, Dilip C, Shinu C. Drug use evaluation of diabetes mellitus in hospitalized patients of a tertiary care referral hospital. J Basic Clin Physiol Pharmacol 2012;23:173-7.
Ayinalem GA, Gelaw BK, Belay AZ, Linjesa JL. Drug use evaluation of ceftriaxone in medical ward of dessie referral Hospital, North East Ethiopia. Int J Basic Clin Pharmacol 2013;2:711-7.
Sultana G, Kapur P, Aqil M, Alam MS, Pillai KK. Drug utilization of oral hypoglycemic agents in a university teaching hospital in India. J Clin Pharm Ther 2010;35:267-77.
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014;103:137-49.
International Diabetes Federation. Diabetes in Iran: Available from: https://www.idf.org/membership/mena/iran. [Last accessed on 20 Nov 2014].
Norris SL, Lee NJ, Severance S. Drug class review: newer drugs for the treatment of diabetes mellitus: Final Report [Internet]. Portland (OR): Oregon Health and Science University: 2008. Available from: http://www.ncbi.nlm.nih.gov/books/NBK10605/. [Last accessed on 20 Nov 2014].
Adepu R, Ari SM. Influence of structured patient education on therapeutic outcomes in diabetes and hypertensive patients. Asian J Pharm Clin Res 2010;3:174–8.
Sharma SK, Ruggenenti P, Remuzzi G. Managing hypertension in diabetic patients focus on trandolapril/ verapamil combination. Vasc Health Risk Manage 2007;3:453-65.
Alldredge BK, Corelli RL, Ernst ME. eds. Koda-Kimble, Young’s. Applied Therapeutics: The Clinical Use of Drugs. 10th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2013.
Odili VU, Obiri EN. Medication use evaluation in diabetes mellitus in a secondary health care facility. West Afr J Pharm 2013;24:32-8.
Truter I. An investigation into antidiabetic medication prescribing in South Africa. J Clin Pharm Ther 1998;23:417-22.
Dinesh KU, Subish P, Pranaya M, Shankar PR, Anil SK, Durga B. Prescribing pattern in diabetic outpatients in a tertiary care teaching hospital in Nepal. Med J Malaysia 2007;62:294-8.
Acharya KG, Shah KN, Solanki ND, Rana DA. Evaluation of antidiabetic prescriptions, cost and adherence to treatment guidelines: a prospective, cross-sectional study at a tertiary care teaching hospital. J Basic Clin Pharm 2013;4:82-7.
Yusefzadeh G, Sepehri G, Goodarzi H, Shokoohi M. Prescription pattern study in type 2 diabetes mellitus in diabetic out patients in private clinics in Kerman, Iran. Br J Med Med Res 2014;4:5144-53.
de Pablos-Velasco PL, MartÃnez-MartÃn FJ, Molero R, RodrÃguez-Perez F, GarcÃa-Puente I, Caballero A. Patterns of prescription of hypoglycaemic drugs in Gran Canaria (Canary Islands, Spain) and estimation of the prevalence of diabetes mellitus. Diabetes Metab 2005;31:457-62.
de Pablos Velasco P, Franch J, Banegas Banegas JR, Fernández Anaya S, Sicras Mainar A, DÃaz Cerezo S. Cross-sectional epidemiological study of clinical profiles and glycemic control in diabetic patients in primary care in Spain (the EPIDIAP study). Endocrinol Nutr 2009;56:233-40.
Fabian W, Majkowska L, Stefański A, Moleda P. Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners. Przegl Lek 2005;62:201-5.
Van den Brink G, Schwartzenberg RR, Hoeve LJ, Porsius AJ, Hoeve LL. The use of hypoglycaemic and cardiovascular drugs in 582 patients with diabetes mellitus. Pharm World Sci 1993;15:128-31.
Quaglia NB, Nuñez MH, Marzi MM. Drug prescriptions and demographic indicators in a diabetic population in Argentina. Farm Hosp 2012;36:92-6.
Haghdoost AA, Rezazadeh-Kermani M, Sadghirad B, Baradaran HR. Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis. Eastern Mediterranean Health J 2009;15:591-9.
Jimoh AO, Sabir AA, Chika A, Sani Z. Pattern of antidiabetic drugs use in a diabetic outpatient clinic of a tertiary health institution in Sokoto, North-western Nigeria. J Med Sci 2011;11:241-5.
Patel B, Oza B, Patel KP, Malhotra SD, Patel VL. Pattern of antidiabetic drugs use in type-2 diabetic patients in a medicine outpatient clinic of a tertiary care teaching hospital. Int J Basic Clin Pharmacol 2013;2:485-91.
Sarumathy S, Ravichandiran V, Mohammed Sulaiman Sait J, Manjula Devi K. A study on drug use pattern and cost impact of antidiabetic drugs in type 2 diabetic patients in a secondary care hospital. World J Pharm Pharm Sci 2013;2:5913-9.
Cheong C, Barner JC, Lawson KA, Johnsrud MT. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among texas medicaid recipients. Clin Ther 2008;30:1893-907.
Jafarian Amiri SR, Zabihi A, Babaieasl F, Eshkevari N, Bijani A. Self care behaviors in diabetic patients referring to diabetes clinics in babol city, Iran. J Babol Univ Med Sci 2010;12:72-8.
Dey L, Attele AS, Yuan CS. Alternative therapies for type 2 diabetes. Altern Med Rev 2002;7:45-58.
Insulin Side Effects. Available from: http://www.drugs.com/ sfx/insulin-side-effects.html. [Last accessed 20 May 2014].
Nathan D. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Diabetologia 2009;52:17-30.
Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, et al. Statement by an American association of clinical endocrinologists/American college of endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract 2009;15:540-59.
Management of diabetes; 2014. Available from: www.sign.ac.uk/pdf/sign116.pdf. [Last accessed 17 Oct 2014].
IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabetic Med 2006;23:579-93.
Sibal L, Home PD. Management of type 2 diabetes: NICE guidelines. Clin Med 2009;9:353-7.
Johnson JA, Pohar SL, Secnik K, Yurgin N, Hirji Z. Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001. BMC Health Serv Res 2006;6:159.
Yurgin N, Secnik K, Lage MJ. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study. Clin Ther 2007;29:316-25.
Vengurlekar S, Shukla P, Patidar P, Bafna R, Jain S. Prescribing pattern of antidiabetic drugs in Indore city hospital. Indian J Pharm Sci 2008;70:637-40.
Abdi SAH, Churi S, Kumar YR. Study of drug utilization pattern of antihyperglycemic agents in a South Indian tertiary care teaching hospital. Indian J Pharmacol 2012;44:210-4.
Bhattacharyya OK, Estey EA, Cheng AY. Canadian Diabetes Association 2008. Update on the canadian diabetes association 2008 clinical practice guidelines. Am Fam Physician 2009;55:39-43.
Moumenan A, Azizi F. Pattern of aspirin use among adults with diabetes: Tehran lipid and glucose study. Iranian J Endocrinol Metab 2004;5:363-70.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA 2014;311:507-20.
Das P, Das BP, Rauniar GP, Roy RK, Sharma SK. Drug utilization pattern and effectiveness analysis in diabetes mellitus at a tertiary care centre in eastern Nepal. Indian J Physiol Pharmacol 2011;55:272-80.